← Back to results

◐ Forecasted · CDC-RFA-JG-26-0142

Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in India

Centers for Disease Control-GHC  ·  HHS

CFDA Numbers

93.067, 93.494

Award Ceiling

Award Floor

Expected Awards

2

Close Date

Jun 12, 2026

Section I

How to Apply

View on grants_gov ↗

Program Contact


pepfarfoas@cdc.gov
pepfarfoas@cdc.gov

Section II

Eligibility

Eligible Applicant Types

00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 99

Section III

Description

The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $6,000,000 for Year 1, subject to the availability of funds.This NOFO supports India’s National AIDS Control Organization (NACO), Central Tuberculosis Division (CTD), and other departments in the Ministry of Health and Family Welfare (MoHFW). The goal is to enhance systems that accelerate and sustain epidemic control, in line with the National AIDS Control Program (NACP)-VI and the National TB Elimination Program (NTEP), while working to eradicate HIV and TB as public health threats.The NOFO aims to transition essential services to local ownership and foster cooperation with interest holders at all levels. To accomplish this goal you should incorporate innovative and evidence-based strategies to:• Prevent new infections.• Facilitate early case detection.• Ensure seamless linkage to care.• Promote treatment adherence.• Achieve viral suppression. Key activities include:• Closing gaps in HIV and TB testing and treatment.• Delivering integrated services for HIV and co-morbidities.• Strengthening program cooperation and ownership to enhance national efforts.• Improving prevention, detection, and response to infectious diseases.Advancing innovative HIV and TB service delivery under local leadership will create a sustainable framework for epidemic control that aligns with U.S. global health priorities, ultimately saving lives and bolstering global health security.

Section IV

Key Dates

Posted
Apr 10, 2026
Closes
Jun 12, 2026
Archive
Jul 12, 2026